Dr. Markus Ackermann

Dr. Markus Ackermann

Dr. Markus Ackermann studied biochemistry at the University of Regensburg, neuroscience at the Pennsylvania State University and received his PhD from the Ludwig Maximilian University in Munich.

He works mainly in the technical fields of pharmaceutical chemistry as well as pharmaceutical research, biochemistry, biotechnology and genetic engineering, polymer chemistry and general organic and inorganic chemistry.

He has experience in patent and utility model prosecution, opposition and nullity proceedings and patent infringement proceedings. In addition, Markus Ackermann is intensively involved in supplementary protection certificates in his professional work. He speaks German, English and French.

Markus Ackermann is a German patent attorney and a professional representative before the EPO. He is also an author and seminar leader for various graduate schools.

Selected publications:

  • GRUR 2022, 683.: Die „inhärente“ Trennlinie zwischen BGH und EPA
  • GRUR Int. 2021, 3: No Need for ‘Plausibility’ in German Patent Law
  • GRUR 2018, 772: Schützt ein Wirkstoffpatent vor „Prodrugs“?